Breast Video Channel
Explore the latest insights and summaries from experts in Breast.
Treatment Landscape
Nebraska Oncology Society
ASTRO Guidelines Updates for Partial Breast Irradiation: 4 Key Questions to Consider
FEATURING
Reshma Jagsi
- 109 views
- April 9, 2024
- 2
Nebraska Oncology Society
Early Stage TNBC Updates
FEATURING
Jairam Krishnamurthy
- 102 views
- April 9, 2024
- 1
Nebraska Oncology Society
Recent Advances in TNBC
FEATURING
Jairam Krishnamurthy
- 134 views
- April 9, 2024
- 1
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Radiation Treatment Considerations
FEATURING
Reshma Jagsi
- 69 views
- April 10, 2024
Nebraska Oncology Society
2024 Updates in mTNBC
FEATURING
Jairam Krishnamurthy
- 121 views
- April 10, 2024
- 1
London Breast Meeting
Updates in Systemic Therapy in mBC
FEATURING
Cornelia Leo
- 51 views
- April 16, 2024
- 1
London Breast Meeting
IO in Breast Cancer: Harnessing the Power of the Immune System
FEATURING
Alicia Okines
- 39 views
- April 16, 2024
London Breast Meeting
Treatment Options for Elderly and Multimorbid BC Patients
FEATURING
Cornelia Leo
- 59 views
- April 16, 2024
- 3
Cedars Sinai
2024 Updates in eBC Treatment for Postmenopausal HR+/HER2- Patients
FEATURING
Yuan Yuan
- 250 views
- April 18, 2024
- 2
University of Colorado Cancer Center
Optimal Treatment for Early Stage HER2+ BC: Tailoring Treatment to Response
FEATURING
Virginia Borges
- 346 views
- May 1, 2024
- 4
Lilly Medical Affairs
Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and Sequencing
FEATURING
Joyce O’Shaughnessy
- 1,780 views
- July 24, 2024
- 10
Lilly Medical Affairs
CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC
FEATURING
Joyce O’Shaughnessy
- 2,378 views
- July 24, 2024
- 13
Sara Tolaney
ASCO® 2024 Noteworthy Abstracts in Breast Cancer
FEATURING
Hope Rugo
- 932 views
- May 24, 2024
- 10
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Community Oncologists Highlights"
FEATURING
Sara Tolaney,
Hope Rugo
- 1,123 views
- May 24, 2024
- 11
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Summary: "Rapid Insights"
FEATURING
Sara Tolaney,
Hope Rugo
- 59 views
- May 28, 2024
Insights from ESMO Breast 2024 Annual Meeting
Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Award Lecture
FEATURING
Hope Rugo
- 1,204 views
- June 7, 2024
- 10
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice
FEATURING
Sara Tolaney,
Hope Rugo
- 4,304 views
- June 7, 2024
- 30
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Panel Discussion: "Key Updates in Breast Cancer"
FEATURING
Sara Tolaney,
Hope Rugo
- 941 views
- June 10, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Treatment and Outcomes in Select Subpopulations With Breast Cancer"
FEATURING
Lisa Carey
- 352 views
- June 18, 2024
- 2
Miami Cancer Institute Precision Oncology Symposium
Precision Therapy for HR+/HER2- mBC
FEATURING
Joyce O'Shaughnessy
- 517 views
- July 2, 2024
- 7
2024 ASCO® Annual Meeting Insights Hub
Management of Higher Risk eBC Including BRCAm, HER2- Subtypes
FEATURING
Milana Dolezal
- 363 views
- July 2, 2024
- 3
ecancer
ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials
FEATURING
Bishal Gyawali
- 105 views
- July 2, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"
FEATURING
Sara Tolaney,
Hope Rugo
- 929 views
- July 4, 2024
- 5
UChicago Medicine
Advances in Targeted and Endocrine Therapies for Metastatic HR+/HER2- Breast Cancer
FEATURING
Nan Chen
- 521 views
- July 11, 2024
- 3
UNC Lineberger Comprehensive Cancer Center
Updates in the Surgical Management for Breast Cancer
FEATURING
Kristalyn Gallagher
- 233 views
- July 19, 2024
- 5
ecancer
Best of ASCO®️ 2024: Adjuvant and Metastatic Indications of HR+ BC
FEATURING
Aurelio Castrellon
- 120 views
- August 2, 2024
- 1
Integrity CE
Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates
- 238 views
- August 2, 2024
- 1
Avan Armaghani
ASCO® 2024 Review: Treatment Updates on TNBC and HR+/HER2- Breast Cancer
- 279 views
- August 9, 2024
- 2
University of Illinois Cancer Center
Key Updates and Insights on HER2+ Breast Cancer
FEATURING
V.K. Gadi
- 175 views
- August 20, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in Early Stage BC
FEATURING
Frederick Howard
- 234 views
- August 26, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in mBC
FEATURING
Sudha Yarlagadda
- 76 views
- August 27, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO 2024 Highlights: Insights From Key Abstracts on mBC
FEATURING
Sramila Aithal
- 184 views
- August 27, 2024
- 2
Alessia Pellerino
Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addressing Unmet Needs
- 163 views
- August 29, 2024
- 2
Katarzyna Jerzak
Advancements in Treatment Strategies for HR+/HER2- mBC: Current and Future Perspectives
- 178 views
- August 29, 2024
- 1
Sara Tolaney
ESMO 2024 Noteworthy Abstracts in Breast Cancer
FEATURING
Hope Rugo
- 557 views
- August 30, 2024
- 9
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Hypo vs. Normofractionated RT in eBC - 5-Year Results of HypoG-01
FEATURING
Sofia Rivera
- 164 views
- September 20, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, DESTINY-BREAST12, and CAPItello-290
FEATURING
Virginia Kaklamani
- 539 views
- September 23, 2024
- 7
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
Evolution of Treatment Algorithms for HER2+ mBC
FEATURING
Mridula George
- 362 views
- September 26, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients With Bone Metastases
FEATURING
Robbe Van den Begin
- 459 views
- September 26, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in mBC
FEATURING
Giampaolo Bianchini
- 532 views
- October 1, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: eBC Panel Discussion on Key Studies - KEYNOTE-522, I-SPY 2.2, and NATALEE
FEATURING
Sara Tolaney,
Hope Rugo
- 586 views
- October 4, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Breast12, CAPItello-290, and ICARUS-BREAST01
FEATURING
Sara Tolaney,
Hope Rugo
- 556 views
- October 4, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: T-DXd in HER2+ mBC With or Without Brain Metastases - DESTINYBreast-12 Primary Results
FEATURING
Nancy Lin
- 214 views
- October 8, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Tailoring Therapy in TNBC and Beyond
FEATURING
Lisa Carey
- 370 views
- October 8, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Systemic Treatment for ILCs in Breast Cancer
FEATURING
Jens Huober
- 342 views
- October 17, 2024
- 4
Yale Cancer Center
Key Trials and Updates in Breast Cancer: Expert Insights
FEATURING
Maryam Lustberg
- 193 views
- October 21, 2024
- 4
COR2ED The Heart of Medical Education
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, DESTINY-Breast12, and NATALEE
FEATURING
François-Clément Bidard
- 40 views
- October 25, 2024
Claudine Isaacs
mBC Updates: DESTINY-Breast06 Trial - 1L T-DXd vs. Chemo in HR+ HER2-Low & HER2-Ultralow Disease
- 230 views
- November 4, 2024
- 3
Total Health
Overview of Early Stage HER2+ BC Updates
FEATURING
Sonia Benn
- 45 views
- November 5, 2024
- 1
Total Health
Overview of Early Stage HR+/HER2- BC Updates
FEATURING
Sonia Benn
- 118 views
- November 5, 2024
- 1
Andrew Redfern
Something Old, New, or Borrowed: Optimizing 2L Therapy in HR+ HER2- mBC Post-CDK4/6 Inhibition
- 90 views
- November 15, 2024
- 3
Daniele Generali
Navigating Treatment Sequencing Post T-DXd Progression for HER2+ mBC
- 16 views
- November 15, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Residual Cancer Burden & Adjuvant Capecitabine in Early TNBC With Non-pCR
FEATURING
Sung-Bae Kim
- 66 views
- November 15, 2024
- 1
University of Illinois Cancer Center
HR+/HER2- Early Breast Cancer: Risk Assessment and Treatment Updates
FEATURING
V.K. Gadi
- 201 views
- November 19, 2024
- 4
Icahn School of Medicine at Mount Sinai
De-Escalation of Systemic Therapy For Early Stage Breast Cancer
FEATURING
Amy Tiersten
- 135 views
- November 19, 2024
- 4
Sara Tolaney
SABCS 2024 Noteworthy Abstracts in Early Breast Cancer
FEATURING
Hope Rugo
- 613 views
- November 19, 2024
- 9
Sara Tolaney
SABCS 2024 Noteworthy Abstracts in Metastatic Breast Cancer
FEATURING
Hope Rugo
- 528 views
- November 19, 2024
- 6
Antonio Llombart Cussac
Integrating HER2-Low Targeted Therapies Into the Luminal mBC Treatment Landscape
- 134 views
- November 20, 2024
- 1
Yale Cancer Center
Breast Medical Oncology: A Multidisciplinary and Personalized Cancer Care Approach
FEATURING
Sarah Schellhorn Mougalian
- 36 views
- November 25, 2024
Nebraska Oncology Society
2024 Updates in Reconstructive Surgery for Breast Cancer
FEATURING
Marco Maricevich
- 18 views
- April 9, 2024
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Selective RT Omission After Breast-Conserving Surgery
FEATURING
Reshma Jagsi
- 91 views
- April 10, 2024
- 2
Kirollos Hanna
Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC
- 2,253 views
- July 19, 2024
- 5
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
De-Escalation of Radiation in Breast Cancer: Finding the Optimal Balance
FEATURING
Bruce Haffty
- 34 views
- November 19, 2024
- 2
Margaret Gatti-Mays
Immunotherapy for TNBC: Remaining Questions and New Directions
- 149 views
- November 27, 2024
- 2
Nebraska Oncology Society
Advances in Adjuvant RT for Localized BC: Regional Nodal Irradiation
FEATURING
Reshma Jagsi
- 22 views
- April 10, 2024
ecancer
Choosing Wisely for Young Women With Breast Cancer: Radiotherapy
FEATURING
Tabassum Wadasadawala
- 19 views
- October 25, 2024
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC
FEATURING
Rita Nanda
- 255 views
- March 1, 2024
- 5
UChicago Medicine
Neoadjuvant & Adjuvant Therapy for HER2+, High-Risk, Early Stage BC
FEATURING
Rita Nanda
- 289 views
- March 1, 2024
- 1
UChicago Medicine
2024 Neoadjuvant IO Updates for HR+ BC
FEATURING
Gini Fleming
- 120 views
- March 1, 2024
- 1
UChicago Medicine
2024 (Neo)Adjuvant Systemic Therapy Updates for HR+ BC
FEATURING
Gini Fleming
- 516 views
- March 1, 2024
- 4
Dana-Farber Cancer Institute
Older Adults With Breast Cancer: Research Updates
FEATURING
Rachel Freedman
- 221 views
- March 1, 2024
- 1
Total Health
Neoadjuvant ET for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 200 views
- March 2, 2024
- 3
Total Health
Neoadjuvant Chemo for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 983 views
- March 2, 2024
- 5
Insights from 2023 SABCS
SABCS 2023 Insights: "Optimizing Adjuvant Endocrine Therapy for Premenopausal Women"
FEATURING
Vered Stearns
- 461 views
- March 2, 2024
- 2
UChicago Medicine
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CAm Tumors, Capivasertib for AKT Pathway-Altered Tumors
FEATURING
Nan Chen
- 222 views
- March 4, 2024
- 1
UChicago Medicine
2024 Updates on ADCs in HER2-Low, HR+, and TNBC
FEATURING
Hope Rugo
- 201 views
- March 4, 2024
- 3
Total Health
Advances in Early Stage TNBC: Post-Neoadjuvant Therapy
FEATURING
Melinda Telli
- 130 views
- March 7, 2024
- 4
Total Health
Advances in Early Stage TNBC: IO Progress and Future Direction
FEATURING
Melinda Telli
- 38 views
- March 7, 2024
Total Health
Advances in Early Stage TNBC: Treatment Progress
FEATURING
Melinda Telli
- 137 views
- March 7, 2024
- 2
Total Health
Current Adjuvant Treatment in BRCA+ BC
FEATURING
Gregory Vidal
- 82 views
- March 12, 2024
- 1
Total Health
Current Adjuvant Treatment in HR+ BC
FEATURING
Gregory Vidal
- 156 views
- March 12, 2024
- 2
Total Health
Current Adjuvant Treatment in HER2+ BC
FEATURING
Gregory Vidal
- 252 views
- March 12, 2024
- 1
Total Health
Antibody Drug Conjugates: Highlights in Breast Cancer
FEATURING
Kevin Kalinsky
- 315 views
- March 12, 2024
- 1
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 2L Setting
FEATURING
Ruth O'Regan
- 450 views
- March 12, 2024
- 2
Total Health
Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted Therapy in the 1L Setting
FEATURING
Ruth O'Regan
- 1,369 views
- March 12, 2024
- 4
Scripps Health
CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC
FEATURING
Sarah Sammons
- 1,750 views
- March 19, 2024
- 10
Scripps Health
2024 Neuro-Oncology Update: Breast Cancer and Brain Mets
FEATURING
Tresa McGranahan
- 368 views
- April 2, 2024
- 3
Yale Cancer Center
Breast Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Therapy
FEATURING
Charles Balch
- 154 views
- April 3, 2024
- 1
Nebraska Oncology Society
Axillary Management Considerations After Neoadjuvant Chemotherapy for Breast Cancer
FEATURING
Olga Kantor
- 16 views
- April 10, 2024
Nebraska Oncology Society
Omission of SLNB in Early Stage BC
FEATURING
Olga Kantor
- 15 views
- April 10, 2024
London Breast Meeting
Lymphedema Preventative Strategies
FEATURING
Ketan Patel
- 13 views
- April 16, 2024
London Breast Meeting
What's on the Horizon? Breast Reconstruction With Perforator Flaps
FEATURING
Koenraad Van Landuyt
- 73 views
- April 16, 2024
- 1
Lilly Medical Affairs
Communicating the Risk of Recurrence for Patients With HR+, HER2- Early Breast Cancer
FEATURING
Joyce O’Shaughnessy
- 549 views
- October 23, 2024
- 2
Bruce Haffty
Omitting PMRT or Nodal RT in Breast Cancer After Node Conversion: NRG B51 Insights
- 96 views
- August 9, 2024
- 2
Sheldon Feldman
New Approaches to Decrease the Risk of Breast Cancer-Related Lymphedema
- 65 views
- August 27, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: A Registry-Based Study of pCR & Survival After Neoadjuvant Chemo in Stage I TNBC
FEATURING
Manon De Graaf
- 46 views
- October 1, 2024
- 1
Kathryn Post
Perspectives on the Effects of Time Toxicity in Breast Cancer Treatment
FEATURING
Jennifer Hutchinson
- 627 views
- October 3, 2024
- 3
Yale Cancer Center
Axillary Management: To Dissect or Not to Dissect
FEATURING
Ellie Proussaloglou
- 33 views
- October 21, 2024
Yale Cancer Center
Radiation Therapy for Breast Cancer: Basics, Historical Perspectives, and Recent Advances
FEATURING
Meena Moran
- 16 views
- November 25, 2024
Yale Cancer Center
Reconstruction Options After Breast Cancer
FEATURING
Siba Haykal
- 25 views
- November 25, 2024
Yale Cancer Center
Breast Reconstruction: Options and Approaches
FEATURING
Paris Butler
- 27 views
- November 25, 2024
University of Illinois Cancer Center
Key Updates in Metastatic HER2+++ Breast Cancer
FEATURING
V.K. Gadi
- 14 views
- December 6, 2024
University of Illinois Cancer Center
Optimizing Treatment Sequencing for Metastatic TNBC
FEATURING
V.K. Gadi
- 4 views
- December 6, 2024
University of Illinois Cancer Center
Metastatic HR+/HER2- BC: CDK4/6 Inhibitor Insights and Next-Line Treatment Options
FEATURING
V.K. Gadi
- 44 views
- December 6, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd
FEATURING
Sara Tolaney
- 2 views
- December 17, 2024
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer
FEATURING
Christos Vaklavas
- 83 views
- December 17, 2024
- 4
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer
FEATURING
Laszlo Tabar
- 44 views
- December 17, 2024
- 3
